SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017397
Filing Date
2022-08-15
Accepted
2022-08-15 16:46:18
Documents
73
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtyx-20220630.htm   iXBRL 10-Q 4054969
2 EX-10.1 vtyx-ex10_1.htm EX-10.1 506443
3 EX-31.1 vtyx-ex31_1.htm EX-31.1 22124
4 EX-31.2 vtyx-ex31_2.htm EX-31.2 22145
5 EX-32.1 vtyx-ex32_1.htm EX-32.1 13525
6 EX-32.2 vtyx-ex32_2.htm EX-32.2 13546
  Complete submission text file 0000950170-22-017397.txt   12834989

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtyx-20220630_cal.xml EX-101.CAL 52020
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtyx-20220630_lab.xml EX-101.LAB 471493
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtyx-20220630_def.xml EX-101.DEF 222586
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtyx-20220630.xsd EX-101.SCH 52981
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtyx-20220630_pre.xml EX-101.PRE 371067
67 EXTRACTED XBRL INSTANCE DOCUMENT vtyx-20220630_htm.xml XML 2434995
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40928 | Film No.: 221166299
SIC: 2834 Pharmaceutical Preparations